Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 1.2.2021 | EN | Official Journal of the European Union | C 35/50 |

---

Order of the General Court of 4 December 2020 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)

(Case T-792/19) [(1)](#ntr1-C_2021035EN.01005002-E0001)

(EU trade mark - Opposition proceedings - Withdrawal of the opposition - No need to adjudicate)

(2021/C 35/66)

Language of the case: German

Parties

Applicant: Agepha Pharma s.r.o. (Senec, Slovakia) (represented by: D. Göbel, lawyer)

Defendant: European Union Intellectual Property Office (represented by: D. Walicka, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Apogepha Arzneimittel GmbH (Dresden, Germany) (represented by: A. Marx and R. Kaase, lawyers)

Re:

Action brought against the decision of the Second Board of Appeal of EUIPO of 26 August 2019 (Case R 386/2019-2), relating to opposition proceedings between Apogepha Arzneimittel GmbH and Agepha Pharma s.r.o.

Operative part of the order

|  |  |
| --- | --- |
| 1. | There is no longer any need to adjudicate on the action. |

|  |  |
| --- | --- |
| 2. | Agepha Pharma s.r.o and Apogepha Arzneimittel GmbH shall bear their own costs and shall each pay half of the costs incurred by the European Union Intellectual Property Office (EUIPO). |

---

---

[Top](#document1)